|
|
Qiagen NV (QGEN)This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below. From 1Table of contents
Company Information:Company Address: Spoorstraat 50 Venlo, 5911 KJ
Company’s Web Address: http://www.qiagen.com/
Industry Sector:
Fiscal Year: Dividend:
Note: this section is not editable.
Please click here to report any inaccuracies.
Company Overview:Note: this section is not editable.
Qiagen N.V. (QGEN) is a research services and diagnostic company. It is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids (DNA/RNA). It offers a broad range of consumables and instruments which are sold to academic research markets and to pharmaceuticals and biotechnology customers in more than 40 countries. Qiagen also provides purification and testing solutions to applied testing markets such as forensics, animal or food testing, and pharmaceutical process control. Other applications for its products include molecular diagnostics, genetic vaccination, and gene therapy. The company has set up a joint venture with Becton, Dickinson and Company, called PreAnalytiX GmbH, which caters to the molecular diagnostic market. The purpose of this joint venture is to develop, manufacture, and market integrated systems for molecular diagnostic testing in association with Affymetrix's GeneChip technology. The company recently acquired Digene which further expands its molecular diagnostics business. Qiagen has a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, nucleic acid and protein handling, separation, and purification and open and target- specific assays. The main product categories are Consumables and Instrumentation. The company also offers customized services, siRNA synthesis, whole genome amplification services, DNA sequencing, and non-cGMP DNA production on a contract basis. Qiagen has subsidiaries in the U.S., Germany, the U.K., Switzerland, France, Japan, China, Australia, Canada, Norway, and several other countries with good sales potential. The company derives the bulk of its revenue from Europe, the U.S., and Japan. Based in Venlo, the Netherlands, it employs 2,662 people worldwide.
Valuation:Enter Valuation Analysis and Valuation Ratios Here
Projected Financials:Income Statement: (Paste Here) Balance Sheet: (Paste Here) Cash Flow Statement: (Paste Here) Financial Ratios: (Paste Here) Other: (Paste Here) News:
Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
|
||||||||||||||||||||||||||||||
|
|